Clinical trial
Letrozole After Tamoxifen in Treating Women With Breast Cancer
NCT00003140 · NCIC Clinical Trials Group, Other · Completed
Key facts
| NCT number | NCT00003140 |
|---|---|
| Title | Letrozole After Tamoxifen in Treating Women With Breast Cancer |
| Official title | A Phase III Randomized Double Blind Study of Letrozole Versus Placebo in Women With Primary Breast Cancer Completing Five or More Years of Adjuvant Tamoxifen |
| Lead sponsor | NCIC Clinical Trials Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH North Central Cancer Treatment Group ETOP IBCSG Partners Foundation Eastern Cooperative Oncology Group SWOG Cancer Research Network Cancer and Leukemia Group B… |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Other |
| Interventions | letrozole, placebo |
| Enrollment | 5,187 |
| Start date | Aug 24, 1998 |
| Primary completion | Aug 22, 2003 |
| Completion | Oct 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 16, 2020 |
| Countries | Canada, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: